TOOLS: What is your favorite biotech stock worth when itβs time for a Big Pharma license deal?
This biotech model generates risk-adjusted values broken down on both licensor and licensee. πππ¬π§¬π§ͺ
π The template can easily be adapted to raw material exploration projects. Or any risk-adjusted project with heavy investments upfront and revenues far ahead in the future.
Β
Also, prints nicely to one horizontal A4.
Β
π Most biotech R&D companies have no ambition to bring their projects all the way to the market.
Β
Instead they target to get through Phase β¦
Keep reading with a 7-day free trial
Subscribe to Emergers.io to keep reading this post and get 7 days of free access to the full post archives.